Click here to enlarge imagePilot testing has shown that FXB biological nitrate treatment is efficient: 45 mg/L of nitrate can be eliminated at empty-bed contact times as low as 10 minutes (~3 gpm/ft2). To achieve this, approximately 14 mg/L of acetic acid-carbon would be dosed to the influent of the FXB bioreactor. The effluent biodegradable organic carbon concentration, which includes any residual acetic acid, is below the analytical detection limit (~0.1 mg/L as carbon). This is significant, as it indicates that product water from this process has very low regrowth potential.
Robustness testing has shown that process performance is negligibly impacted by fluctuations in raw nitrate concentration (step or gradual changes of 5-10 mg/L), backwashing events, periods of system shut-down (tested up to two weeks), and simulated acetic acid feed failures (up to 24 hours of no electron donor feed). As a result of this pilot testing performance, FXB biological processes have received approval from the California Department of Health Services for the removal of nitrate from drinking water in full-scale systems.
Design and operation of FXB bioreactors are comparable to the design and operation of conventional granular media filters. O&M costs can be as low as $0.15/1000 gallons ($50/AF) and water recoveries are typically greater than 97%. As an added benefit, a single FXB bioreactor can simultaneously destroy nitrate, perchlorate, tastes, odors, color, disinfection by-product precursors, regrowth potential, and chlorinated solvents.
Nitrate destruction eliminates the need for concentrate handling, making this technology sustainable. As residuals handling costs continue to increase, FXB bioreactors may become an increasingly important treatment option for utilities dealing with nitrate contamination.
About the Author:
Jess Brown, PhD, is the Carollo Engineers Research Group manager and one of the firm’s biological drinking water treatment experts. He has eight years’ experience in water and wastewater treatment specializing in treatment processes and applied research. Dr. Brown may be contacted via email at [email protected].